CD44 functions in Wnt signaling by regulating LRP6 localization and activation

Cell Death and Differentiation

Volumn 22, Issue 4, 2015, Pages 677-689

  Schmitt, M ^a   Metzger, M ^a   Gradl, D ^b   Davidson, G ^a   Orian Rousseau, V ^a  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; EZRIN; FRIZZLED PROTEIN; HERMES ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; WNT PROTEIN; ACTIN; CYTOSKELETON PROTEIN; HYALURONIC ACID; ISOPROTEIN; LRP6 PROTEIN, HUMAN; PROTEIN BINDING; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; BRAIN DEVELOPMENT; CELL FRACTIONATION; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; EN 2 GENE; EPISTASIS; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TCF 4 GENE; WNT SIGNALING PATHWAY; XENOPUS LAEVIS; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; OOCYTE; RNA INTERFERENCE; TUMOR CELL LINE;

ACTINS; ANIMALS; ANTIGENS, CD44; BETA CATENIN; CELL LINE, TUMOR; CYTOSKELETAL PROTEINS; HEK293 CELLS; HELA CELLS; HUMANS; HYALURONIC ACID; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-6; OOCYTES; PROTEIN BINDING; PROTEIN ISOFORMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; WNT PROTEINS; WNT SIGNALING PATHWAY; XENOPUS LAEVIS;

EID: 84925463106     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.156     Document Type: Article

References (68)

1. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 2004; 20: 781-810.
2. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006; 127: 469-480.
3. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012; 149: 1192-1205.
4. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 4281: 1509-1512.
5. Jho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002; 22: 1172-1183.
6. Yan D, Wiesmann M, Rohan M, Chan V, Jefferson AB, Guo L et al. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors. Proc Natl Acad Sci USA 2001; 98: 14973-14978.
7. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999; 154: 515-523.
8. Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function and association with the malignant process In: Vande Woude GF, Klein G (eds). Advances in Cancer Research. Elsevier: Amsterdam, Netherlands, 1997, pp 243-318.
9. Ponta H, Sherman L, Herrlich PA. CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol. 2003; 4: 33-45.
10. Orian-Rousseau V. CD44, a therapeutic target for metastasising tumours. Eur J Cancer 2010; 46: 1271-1277.
11. Fuchs K, Hippe A, Schmaus A, Homey B, Sleeman JP, Orian-Rousseau V. Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44. Cell Death Dis 2013; 4: e819.
12. Kuhnert F, Davis CR, Wang HT, Chu P, Lee M, Yuan J et al. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci USA 2004; 101: 266-271.
13. Zeilstra J, Joosten SP, van Andel H, Tolg C, Berns A, Snoek M et al. Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling. Oncogene 2014; 33: 665-670.
14. Roca X, Mate JL, Ariza A, Munoz-Marmol AM, von Uexkull-Guldeband C, Pellicer I et al. CD44 isoform expression follows two alternative splicing pathways in breast tissue. Am J Pathol 1998; 153: 183-190.
15. Gansauge F, Gansauge S, Zobywalski A, Scharnweber C, Link KH, Nussler AK et al. Differential expression of CD44 splice variants in human pancreatic adenocarcinoma and in normal pancreas. Cancer Res 1995; 55: 5499-5503.
16. Fonseca I, Moura Nunes JF, Soares J. Expression of CD44 isoforms in normal salivary gland tissue: an immunohistochemical and ultrastructural study. Histochem Cell Biol 2000; 114: 483-488.
17. Shimabukuro K, Toyama-Sorimachi N, Ozaki Y, Goi T, Furukawa K, Miyasaka M et al. The expression patterns of standard and variant CD44 molecules in normal uterine cervix and cervical cancer. Gynecol Oncol 1997; 64: 26-34.
18. Kasper M, Gunthert U, Dall P, Kayser K, Schuh D, Haroske G et al. Distinct expression patterns of CD44 isoforms during human lung development and in pulmonary fibrosis. Am J Respir Cell Mol Biol 1995; 13: 648-656.
19. Mackay CR, Terpe H-J, Stauder R, Marston WL, Stark H, Günthert U. Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 1994; 124: 71-82.
20. Wielenga VJ, Heider KH, Offerhaus GJ, Adolf GR, van den Berg FM, Ponta H et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 1993; 53: 4754-4756.
21. Bloor BK, Jelvagharan M, White KN, Odell EW. Characterization of CD44 splicing patterns in normal keratinocytes, dysplastic and squamous carcinoma cell lines. Int J Oncol 2001; 18: 1053-1059.
22. Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zoller J et al. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 1996; 179: 66-73.
23. Yu Q, Toole BP. Common pattern of CD44 isoforms is expressed in morphogenetically active epithelia. Dev Dyn 1997; 208: 1-10.
24. Wielenga VJ, van der Neut R, Offerhaus GJ, Pals ST. CD44 glycoproteins in colorectal cancer: expression, function, and prognostic value. Adv Cancer Res 2000; 77: 169-187.
25. Zeilstra J, Joosten SP, Dokter M, Verwiel E, Spaargaren M, Pals ST. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. Cancer Res 2008; 68: 3655-3661.
26. Misra S, Hascall VC, De Giovanni C, Markwald RR, Ghatak S. Delivery of CD44shRNA/nanoparticles within cancer cells: perturbation of hyaluronan/CD44v6 interactions and reduction in adenoma growth in Apc Min/+ mice. J Biol Chem 2009; 284: 12432-12446.
27. Chang G, Zhang H, Wang J, Zhang Y, Xu H, Wang C et al. CD44 targets Wnt/beta-catenin pathway to mediate the proliferation of K562 cells. Cancer Cell Int 2013; 13: 117.
28. Misra S, Obeid LM, Hannun YA, Minamisawa S, Berger FG, Markwald RR et al. Hyaluronan constitutively regulates activation of COX-2-mediated cell survival activity in intestinal epithelial and colon carcinoma cells. J Biol Chem 2008; 283: 14335-44.
29. Krejci P, Aklian A, Kaucka M, Sevcikova E, Prochazkova J, Masek JK et al. Receptor tyrosine kinases activate canonical WNT/beta-catenin signaling via MAP kinase/LRP6 pathway and direct beta-catenin phosphorylation. PLoS One 2012; 7: e35826.
30. Bourguignon LY, Peyrollier K, Gilad E, Brightman A. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J Biol Chem 2007; 282: 1265-1280.
31. Koenig SF, Brentle S, Hamdi K, Fichtner D, Wedlich D, En2 Gradl D. Pax2/5 and Tcf-4 transcription factors cooperate in patterning the Xenopus brain. Dev Biol 2010; 340: 318-328.
32. McGrew LL, Takemaru K, Bates R, Moon RT. Direct regulation of the Xenopus engrailed-2 promoter by the Wnt signaling pathway, and a molecular screen for Wnt-responsive genes, confirm a role for Wnt signaling during neural patterning in Xenopus. Mech Dev 1999; 87: 21-32.
33. König H, Moll J, Ponta H, Herrlich P. Trans-acting factors regulate the expression of CD44 splice variants. EMBO J 1996; 15: 4030-4039.
34. Cheng C, Yaffe MB, Sharp PA. A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev 2006; 20: 1715-1720.
35. Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005; 307: 1904-1909.
36. Peach RJ, Hollenbaugh D, Stamenkovic I, Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J Cell Biol 1993; 122: 257-264.
37. Legg JW, Isacke CM. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr Biol 1998; 8: 705-708.
38. Orian-Rousseau V, Chen L, Sleeman JP, Herrlich P, Ponta H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes Dev 2002; 16: 3074-3086.
39. Algrain M, Turunen O, Vaheri A, Louvard D, Arpin M. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol 1993; 120: 129-139.
40. Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P et al. Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 2005; 438: 867-872.
41. Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z et al. A mechanism for Wnt coreceptor activation. Mol Cell 2004; 13: 149-156.
42. Hsieh JC, Lee L, Zhang L, Wefer S, Brown K, DeRossi C et al. Mesd encodes an LRP5/6 chaperone essential for specification of mouse embryonic polarity. Cell 2003; 112: 355-367.
43. Ori M, Nardini M, Casini P, Perris R, Nardi I. XHas2 activity is required during somitogenesis and precursor cell migration in Xenopus development. Development 2006; 133: 631-640.
44. Kunz M, Herrmann M, Wedlich D, Gradl D. Autoregulation of canonical Wnt signaling controls midbrain development. Dev Biol 2004; 273: 390-401.
45. Hidalgo-Sanchez M, Millet S, Bloch-Gallego E, Alvarado-Mallart RM. Specification of the meso-isthmo-cerebellar region: the Otx2/Gbx2 boundary. Brain Res Brain Res Rev 2005; 49: 134-149.
46. Wehrli M, Dougan ST, Caldwell K, O'Keefe L, Schwartz S, Vaizel-Ohayon D et al. arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature 2000; 407: 527-530.
47. Bilic J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, Bienz M et al. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 2007; 316: 1619-1622.
48. Galli C, Piemontese M, Lumetti S, Ravanetti F, Macaluso GM, Passeri G. Actin cytoskeleton controls activation of Wnt/beta-catenin signaling in mesenchymal cells on implant surfaces with different topographies. Acta Biomater 2012; 8: 2963-2968.
49. Marion S, Hoffmann E, Holzer D, Le Clainche C, Martin M, Sachse M et al. Ezrin promotes actin assembly at the phagosome membrane and regulates phago-lysosomal fusion. Traffic 2011; 12: 421-437.
50. Deretic D, Traverso V, Parkins N, Jackson F, Rodriguez de Turco EB, Ransom N. Phosphoinositides, ezrin/moesin, and rac1 regulate fusion of rhodopsin transport carriers in retinal photoreceptors. Mol Biol Cell 2004; 15: 359-370.
51. Orian-Rousseau V, Morrison H, Matzke A, Kastilan T, Pace G, Herrlich P et al. Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Mol Biol Cell 2007; 18: 76-83.
52. Korinek V, Barker N, Willert K, Molenaar M, Roose J, Wagenaar G et al. Two members of the Tcf family implicated in Wnt/beta-catenin signaling during embryogenesis in the mouse. Mol Cell Biol 1998; 18: 1248-1256.
53. Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 2003; 17: 1709-1713.
54. Shibamoto S, Higano K, Takada R, Ito F, Takeichi M, Takada S. Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells 1998; 3: 659-670.
55. Matzku S, Wenzel A, Liu S, Zoller M. Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res 1989; 49: 1294-1299.
56. Sleeman JP, Arming S, Moll JF, Hekele A, Rudy W, Sherman LS et al. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells. Cancer Res 1996; 56: 3134-3141.
57. Avigdor A, Goichberg P, Shivtiel S, Dar A, Peled A, Samira S et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004; 103: 2981-2989.
58. Matzke A, Herrlich P, Ponta H, Orian-Rousseau V. A five-amino-acid peptide blocks Met- and Ron-dependent cell migration. Cancer Res 2005; 65: 6105-6110.
59. Mao B, Wu W, Davidson G, Marhold J, Li M, Mechler BM et al. Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 2002; 417: 664-667.
60. Tamai K, Semenov M, Kato Y, Spokony R, Liu C, Katsuyama Y et al. LDL-receptor-related proteins in Wnt signal transduction. Nature 2000; 407: 530-535.
61. Cruciat CM, Dolde C, de Groot RE, Ohkawara B, Reinhard C, Korswagen HC et al. RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-beta-catenin signaling. Science 2013; 339: 1436-1441.
62. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997; 16: 3797-3804.
63. Feike AC, Rachor K, Gentzel M, Schambony A. Wnt5a/Ror2-induced upregulation of xPAPC requires xShcA. Biochem Biophys Res Commun 2010; 400: 500-506.
64. Landesman Y, Sokol SY. Xwnt-2b is a novel axis-inducing Xenopus Wnt, which is expressed in embryonic brain. Mech Dev 1997; 63: 199-209.
65. Konig A, Gradl D, Kuhl M, Wedlich D. The HMG-box transcription factor XTcf-4 demarcates the forebrain-midbrain boundary. Mech Dev 2000; 93: 211-214.
66. Huang Z, Cheng Y, Chiu PM, Cheung FM, Nicholls JM, Kwong DL et al. Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties. Oncogene 2012; 31: 3709-3720.
67. Peng HB. Xenopus laevis: practical uses in cell and molecular biology. Solutions and protocols. Methods Cell Biol 1991; 36: 657-662.
68. Nieuwkoop PD. The 'organization centre'. 3. Segregation and pattern formation in morphogenetic fields. Acta Biotheor 1967; 17: 178-194.